ꯗꯥꯏꯔꯤ ꯁꯅꯁꯤꯡꯒꯤ ꯁꯨꯡꯕꯥ ꯃꯇꯃꯗꯥ ꯅ꯭ꯌꯨꯠꯔꯤꯁꯟ ꯔꯦꯒꯨꯂꯦꯁꯅꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯄꯣꯏꯟꯇꯁꯤꯡ

ꯑꯍꯥꯅꯕꯥ ꯇꯥꯉ꯭ꯀꯛ (ꯑꯀꯪꯕꯥ ꯁꯉ꯭ꯒꯣꯃꯒꯤ 1ꯗꯒꯤ 40ꯁꯨꯕꯥ ꯅꯨꯃꯤꯠ ꯐꯥꯎꯕꯥ): ꯑꯦꯅꯔꯖꯤ ꯂꯤꯃꯤꯠ ꯇꯧꯕꯥ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯃꯦꯟꯇꯤꯅꯦꯟꯁꯀꯤꯗꯃꯛꯇꯥ (ꯅꯦꯜ 1.25-1.35 MCAL/KG DM), ꯑꯣꯕꯦꯁꯤꯇꯤ. ꯊꯤꯡꯖꯤꯜꯂꯨ꯫

ꯂꯦꯠ ꯁ꯭ꯇꯦꯖ (ꯗꯦꯂꯤꯚꯔꯤꯒꯤ ꯃꯃꯥꯡꯗꯥ ꯅꯨꯃꯤꯠ 21ꯅꯤꯒꯤ ꯃꯃꯥꯡꯗꯥ, i.e. ꯄꯦꯔꯤꯅꯦꯇꯦꯜ ꯄꯤꯔꯤꯌꯗ): ꯑꯦꯅꯔꯖꯤ ꯃꯇꯤꯛ ꯆꯥꯅꯥ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ (ꯅꯦꯜ 1.55-1.65 mcal/kg dm), ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯈꯣꯝꯂꯥꯡꯒꯤ ꯃꯊꯧ ꯇꯥꯕꯁꯤꯡꯗꯥ ꯇ꯭ꯔꯥꯟꯁꯤꯁꯟ ꯇꯧꯕꯥ, ꯑꯗꯨꯕꯨ ꯁ꯭ꯇꯥꯔꯆ ꯗꯥꯏꯠ ꯍꯥꯏꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯑꯦꯁꯤꯗꯣꯁꯤꯁꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯑꯦꯁꯤꯗꯣꯁꯤꯁ ꯊꯤꯡꯖꯤꯜꯂꯨ.

ꯀ꯭ꯔꯨꯗ ꯄ꯭ꯔꯣꯇꯤꯟ (ꯁꯤ.ꯄꯤ.): 12-13% ꯑꯁꯤ ꯑꯍꯥꯅꯕꯥ ꯇꯥꯉ꯭ꯀꯛꯇꯥ, 14-15% ꯂꯦꯠ ꯁ꯭ꯇꯦꯖꯗꯥ (ꯅꯥꯏꯠꯔꯣꯖꯦꯟ ꯔꯤꯖꯔꯚꯔꯁꯤꯡ ꯐꯒꯠꯍꯅꯕꯥ).

ꯔꯨꯃꯦꯟ ꯕꯥꯏꯄꯥꯁ ꯄ꯭ꯔꯣꯇꯤꯟ (ꯔꯨꯞ): 35-40% ꯁꯤ.ꯄꯤ., ꯁꯄꯣꯔꯠ ꯇꯧꯕꯥ ꯐꯤꯇꯁ ꯒ꯭ꯔꯣꯊ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯔꯅꯦꯂꯒꯤ ꯃꯊꯧ ꯇꯥꯕꯁꯤꯡ.

ꯀꯦꯂꯁꯤꯌꯝ: ꯀꯦꯂꯁꯤꯌꯝ ꯏꯅꯇꯦꯛ (ꯃꯌꯥꯏ ꯑꯣꯏꯕꯥ) ꯂꯤꯃꯤꯠ ꯂꯩ꯫<0.5% DM) to prevent postpartum hypocalcemia; anionic salts can be used in the perinatal period (DCAD negative balance).

ꯐꯣꯁꯐꯔꯁ: 0.25-0.35% ꯗꯤ.ꯑꯦꯝ..

ꯚꯤꯇꯥꯃꯤꯟ D/E/ -ꯀꯦꯔꯣꯇꯤꯟ: ꯏꯝꯝꯌꯨꯅꯤꯇꯤ ꯑꯃꯁꯨꯡ ꯀꯦꯂꯁꯤꯌꯝ ꯃꯦꯇꯥꯕꯣꯂꯤꯖꯝ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ (ꯃꯔꯨꯑꯣꯏꯅꯥ ꯚꯤꯇꯥꯃꯤꯟ E 1000-1500 iu/day).

ꯁꯦꯂꯦꯅꯤꯌꯝ: 0{1}}3 ppm, ꯔꯤꯇꯦꯟ ꯇꯧꯔꯕꯥ ꯄ꯭ꯂꯥꯁꯦꯟꯇꯥꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯟꯊꯍꯜꯂꯤ꯫

ꯅ꯭ꯌꯨꯠꯔꯤꯑꯦꯜ ꯗꯤꯇꯔꯖꯦꯟꯇ ꯐꯥꯏꯕꯔ (ꯑꯦꯟ.ꯗꯤ.ꯑꯦꯐ.): ꯳꯵%ꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯆꯥꯎꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯥꯟꯅꯕꯥ, ꯔꯨꯃꯦꯟ ꯍꯦꯜꯊ. ꯁꯣꯌꯗꯅꯥ ꯂꯩꯍꯟꯅꯕꯥ꯫

ꯅꯟ-ꯐꯥꯏꯕꯔ ꯀꯥꯔꯕꯣꯍꯥꯏꯗ꯭ꯔꯦꯠꯁꯤꯡ (ꯑꯦꯟ.ꯑꯦꯐ.ꯁꯤ.):<35% in the early stage, can be increased to 40% in the later stage (but starch content needs to be monitored).

ꯁꯨꯡꯕꯥ ꯁꯉ꯭ꯒꯣꯃꯒꯤ ꯑꯍꯥꯅꯕꯥ ꯇꯥꯉ꯭ꯀꯛꯇꯥ ꯍꯀꯆꯥꯡꯒꯤ ꯐꯤꯚꯝ ꯁꯦꯃꯗꯣꯀꯄꯥ, ꯑꯣꯚꯔꯐꯦꯠ ꯁꯟ-ꯏꯔꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛꯇꯥ ꯑꯦꯅꯔꯖꯤ ꯂꯤꯃꯤꯠ ꯇꯧꯕꯥ, ꯑꯃꯁꯨꯡ ꯑꯣꯚꯔ-ꯊꯤꯟ ꯁꯟ-ꯏꯔꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛꯇꯥ ꯑꯋꯥꯡꯕꯥ ꯊꯥꯛꯀꯤ ꯄ꯭ꯔꯣꯇꯤꯟ ꯁꯞꯂꯤꯃꯦꯟꯇ ꯇꯧꯕꯥ.

ꯔꯨꯃꯦꯟ ꯑꯦꯗꯞꯇꯦꯁꯟ ꯄ꯭ꯔꯣꯃꯣꯠ ꯇꯧꯅꯕꯥ ꯗꯦꯂꯤꯚꯔꯤꯒꯤ ꯃꯃꯥꯡꯗꯥ ꯅꯨꯃꯤꯠ 21ꯅꯤꯒꯤ ꯃꯃꯥꯡꯗꯥ ꯀꯟꯁꯦꯟꯠꯔꯦꯠ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯍꯦꯅꯒꯠꯍꯅꯕꯤꯌꯨ (ꯅꯣꯡꯃꯗꯥ 0.2-0.3ꯀꯤꯂꯣꯒ꯭ꯔꯥꯝ) ꯍꯦꯅꯒꯠꯍꯅꯕꯤꯌꯨ.

ꯀꯦꯇꯣꯁꯤꯁ ꯑꯃꯁꯨꯡ ꯍꯥꯏꯄꯣꯀꯦꯂꯁꯃꯤꯌꯥ. ꯊꯤꯡꯅꯕꯥ ꯕ꯭ꯂꯗ ꯀꯦꯂꯁꯤꯌꯝ ꯑꯃꯁꯨꯡ -ꯍꯥꯏꯗ꯭ꯔꯣꯛꯁꯤꯕ꯭ꯌꯨꯇꯤꯔꯤꯛ ꯑꯦꯁꯤꯗ (BHB) ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯇꯦꯁ꯭ꯠ ꯇꯧꯕꯥ ꯌꯥꯏ꯫

ꯑꯁꯦꯡꯕꯥ ꯊꯛꯅꯕꯥ ꯏꯁꯤꯡ ꯁꯣꯌꯗꯅꯥ ꯂꯩꯍꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯩꯁꯥ ꯄꯤꯖꯕꯥ ꯌꯥꯕꯥ ꯐꯤꯗ.